O
Olivia Keiser
Researcher at University of Geneva
Publications - 268
Citations - 11341
Olivia Keiser is an academic researcher from University of Geneva. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 50, co-authored 236 publications receiving 9928 citations. Previous affiliations of Olivia Keiser include University of Zurich & University of South Florida.
Papers
More filters
Journal ArticleDOI
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Silvia Stringhini,Silvia Stringhini,Silvia Stringhini,Ania Wisniak,Giovanni Piumatti,Giovanni Piumatti,Andrew S. Azman,Andrew S. Azman,Stephen A. Lauer,Hélène Baysson,David De Ridder,Dusan Petrovic,Dusan Petrovic,Stephanie Schrempft,Kailing Marcus,Sabine Yerly,Isabelle Arm Vernez,Olivia Keiser,Samia Hurst,Klara M. Posfay-Barbe,Didier Trono,Didier Pittet,Laurent Getaz,Laurent Getaz,François Chappuis,François Chappuis,Isabella Eckerle,Isabella Eckerle,Nicolas Vuilleumier,Nicolas Vuilleumier,Benjamin Meyer,Antoine Flahault,Antoine Flahault,Laurent Kaiser,Laurent Kaiser,Idris Guessous,Idris Guessous +36 more
TL;DR: The results suggest that most of the population of Geneva remained uninfected during this wave of the pandemic, despite the high prevalence of COVID-19 in the region, and highlight that the epidemic is far from coming to an end by means of fewer susceptible people in the population.
Journal ArticleDOI
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
Gary M. Clifford,Jerry Polesel,Martin Rickenbach,Luigino Dal Maso,Olivia Keiser,Andreas Kofler,Elisabetta Rapiti,Fabio Levi,Gernot Jundt,Thomas Fisch,Andrea Bordoni,Daniel De Weck,Silvia Franceschi +12 more
TL;DR: In persons infected with HIV, HAART use may prevent most excess risk of Kaposi sarcoma and non-Hodgkin lymphoma, but not that of Hodgkins lymphoma and other non-acquired immunodeficiency syndrome-defining cancers.
Journal ArticleDOI
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.
Margalida Rotger,Sara Colombo,Hansjakob Furrer,Gabriela Bleiber,Thierry Buclin,Belle L. Lee,Olivia Keiser,Jérôme Biollaz,Laurent A. Decosterd,Amalio Telenti +9 more
TL;DR: CYP2B6 genotyping may be useful to complement an individualization strategy based on plasma drug determinations to increase the safety and tolerability of EFV.
Journal ArticleDOI
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
Leigh F. Johnson,Joël Mossong,Rob E. Dorrington,Michael Schomaker,Christopher J. Hoffmann,Olivia Keiser,Matthew P. Fox,Matthew P. Fox,Robin Wood,Hans Prozesky,Janet Giddy,Daniela Garone,Morna Cornell,Matthias Egger,Andrew Boulle +14 more
TL;DR: The life expectancies of HIV positive South African adults who are taking antiretroviral therapy are estimated by using information from 6 programmes between 2001 and 2010.
Journal ArticleDOI
Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.
Lyson Tenthani,Lyson Tenthani,Andreas D Haas,Hannock Tweya,Hannock Tweya,Andreas Jahn,Joep J van Oosterhout,Frank Chimbwandira,Zengani Chirwa,Wingston Ng’ambi,Alan Bakali,Sam Phiri,Landon Myer,Fabio Valeri,Marcel Zwahlen,Gilles Wandeler,Olivia Keiser +16 more
TL;DR: Decreasing LTF will improve the effectiveness of the Option B+ approach, and Tailored interventions, like community or family-based models of care could improve its effectiveness.